ANDREA RAMIREZ: Open Payments
NPI 1003015108 · MORRISTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$497 in 23 payments from 11 companies in 2025. Trend: 2023 $671 · 2024 $491 · 2025 $497
Food & beverage: $497
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 4 | $148 |
| ABBVIE INC. | 5 | $90 |
| Lilly USA, LLC | 4 | $73 |
| SHIELD THERAPEUTICS INC | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Ascendis Pharma Endocrinology Inc | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: Fintepla, ACCRUFER, JARDIANCE, MOUNJARO, MAVYRET, QULIPTA, AIRSUPRA, VRAYLAR.
Industry payments across NJ — which companies pay providers there.
